In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb

Clinical and Experimental Immunology

Volumn 103, Issue 3, 1996, Pages 491-498

  Ben Amor, A ^a   Leite De Moraes, M C ^a   Lepault, F ^a   Schneider, E ^a   Machavoine, F ^a   Arnould, A ^a   Chatenoud, L ^b   Dy, M ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CNRS   (France)

Author keywords

Anti CD3 MoAb; Cytokines; IL 2; T cell; Transforming growth factor beta 1; Unresponsiveness

Indexed keywords

CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 2; MITOGENIC AGENT; MONOCLONAL ANTIBODY; OKT 3; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0029872816     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1996.tb08307.x     Document Type: Article

References (30)

1. Leo O, Foo M, Sachs DH et al. Identification of a monoclonal antibody specific for murine T3 polypeptide. Proc Natl Acad Sci USA 1987; 84:1374-8.
2. Cosimi AB. Clinical development of orthoclone OKT3. Transplant Proc 1987; 21:7-16.
3. +, CD4, CD8 TCR-gamma delta-expressing peripheral T cells. J Immunol 1989; 142:3754-62.
4. Scott DE, Gause WC, Finkelman FD et al. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J Immunol 1990; 145:2183-8.
5. Ellenhorn JDI, Hirsch R, Hartley JP et al. Dose-dependent activation of murine T cells following in vivo administration of antimurine CD3. Transplant Proc 1989; 21:1013-4.
6. Ferran C, Sheehan K, Dy M et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20:509-15.
7. Ferran C, Dautry F, Merite S et al. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest 1994; 93:2189-96.
8. Velu T, Durez P, Van Mechelen M et al. In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. Transplant Proc 1993; 25:568-9.
9. Ceuppens JL, Bloemmen FJ, Van Wauwe JP. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex. J Immunol 1985; 135:3882-6.
10. Hirsch R, Gress RE, Pluznik DH et al. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol 1989; 142:737-43.
11. Hirsch R, Eckhaus M, Auchinloss H et al. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. Immunosuppression of transplantation responses. J Immunol 1988; 140:3766-72.
12. Chatenoud L, Thervet E, Primo J et al. Remission of established diabetes in diabetic NOD mice using anti-CD3 monoclonal anti-body. CR Acad Sci 1992; 315:225.
13. 2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 1990; 49:1117-23.
14. Sheehan KCF, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989; 142:3884-93.
15. Schreiber RD, Hicks LJ, Celada A et al. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol 1985; 134:1609-18.
16. Dy M, Lebel B, Schneider E. Histamine-producing cell stimulating factor (HCSF) and interleukin 3: evidence for two distinct molecular entities. J Immunol 1986; 136:208-12.
17. Leite de Moraes MDC, Minoprio P, Dy M et al. Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi. Scand J Immunol 1994; 39:51-58.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
19. Truneh A, Albert F, Golstein P et al. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 1985; 313:318-20.
20. Radvanyi LG, Mills GB, Miller RG. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 1993; 150:5704-15.
21. Rappaport RS, Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982; 155:943-8.
22. Schleifer KW, Mansfield JM. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 1993; 151:5492-503.
23. + T cell clones and resting T cells. J Immunol 1993; 150:4754-65.
24. Alleva DG, Burger CJ, Elgert KD. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation. Immunobiol 1993; 188:430-45.
25. Ahuja SS, Paliogianni F, Yamada H et al. Effect of transforming growth factor beta on early and late activation events in human T cells. J Immunol 1993; 150:3109-18.
26. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-8.
27. Gimmi CD, Freeman GJ, Gribben JG et al. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90:6586-90.
28. Cho EA, Riley MP, Sillman AL et al. Altered protein tyrosine phosphorylation in anergic Th1 cells. J Immunol 1993; 151:20-28.
29. Ellenhorn JDI, Hirsch R, Schreiber H et al. In vivo administration of anti-CD3 prevents maligant progressor tumor growth. Science 1988; 242:569-71.
30. Ellenhorn JDI, Schreiber H, Bluestone JA. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice. J Immunol 1990; 144:2840-6.